The global market for Molecular Diagnostics in Point of Care is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Molecular Diagnostics in Point of Care market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Molecular Diagnostics in Point of Care market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Molecular Diagnostics in Point of Care market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Molecular Diagnostics in Point of Care market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Molecular Diagnostics in Point of Care players cover Abbott, Accelerate Diagnostics, Ador Diagnostics, Beckman Coulter and Becton, Dickinson and Company, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Molecular Diagnostics in Point of Care market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Molecular Diagnostics in Point of Care market, with both quantitative and qualitative data, to help readers understand how the Molecular Diagnostics in Point of Care market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Molecular Diagnostics in Point of Care market and forecasts the market size by Type (Polymerase Chain Reaction, In Situ Hybridization and Gene Chips), by Application (Hospitals and Clinics and Independent Clinical Laboratories.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Polymerase Chain Reaction
In Situ Hybridization
Gene Chips
Next Generation Sequencing
Segmentation by application
Hospitals and Clinics
Independent Clinical Laboratories
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Abbott
Accelerate Diagnostics
Ador Diagnostics
Beckman Coulter
Becton, Dickinson and Company
Binx Health
Biocartis
bioM?rieux
Bio-Rad Laboratories
Bosch Healthcare Solutions
Curetis
Eurofins Scientific
Genetic Signatures
Grifols
Hibergene Diagnostics
Lumos Diagnostics
Roche
Siemens
Thermo Fisher Scientific
Chapter Introduction
Chapter 1: Scope of Molecular Diagnostics in Point of Care, Research Methodology, etc.
Chapter 2: Executive Summary, global Molecular Diagnostics in Point of Care market size and CAGR, Molecular Diagnostics in Point of Care market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Molecular Diagnostics in Point of Care revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Molecular Diagnostics in Point of Care revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Molecular Diagnostics in Point of Care market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Abbott, Accelerate Diagnostics, Ador Diagnostics, Beckman Coulter, Becton, Dickinson and Company, Binx Health, Biocartis, bioM?rieux and Bio-Rad Laboratories, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Molecular Diagnostics in Point of Care Market Size 2017-2028
2.1.2 Molecular Diagnostics in Point of Care Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Molecular Diagnostics in Point of Care Segment by Type
2.2.1 Polymerase Chain Reaction
2.2.2 In Situ Hybridization
2.2.3 Gene Chips
2.2.4 Next Generation Sequencing
2.3 Molecular Diagnostics in Point of Care Market Size by Type
2.3.1 Molecular Diagnostics in Point of Care Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Molecular Diagnostics in Point of Care Market Size Market Share by Type (2017-2022)
2.4 Molecular Diagnostics in Point of Care Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Independent Clinical Laboratories
2.5 Molecular Diagnostics in Point of Care Market Size by Application
2.5.1 Molecular Diagnostics in Point of Care Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Molecular Diagnostics in Point of Care Market Size Market Share by Application (2017-2022)
3 Molecular Diagnostics in Point of Care Market Size by Player
3.1 Molecular Diagnostics in Point of Care Market Size Market Share by Players
3.1.1 Global Molecular Diagnostics in Point of Care Revenue by Players (2020-2022)
3.1.2 Global Molecular Diagnostics in Point of Care Revenue Market Share by Players (2020-2022)
3.2 Global Molecular Diagnostics in Point of Care Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Molecular Diagnostics in Point of Care by Regions
4.1 Molecular Diagnostics in Point of Care Market Size by Regions (2017-2022)
4.2 Americas Molecular Diagnostics in Point of Care Market Size Growth (2017-2022)
4.3 APAC Molecular Diagnostics in Point of Care Market Size Growth (2017-2022)
4.4 Europe Molecular Diagnostics in Point of Care Market Size Growth (2017-2022)
4.5 Middle East & Africa Molecular Diagnostics in Point of Care Market Size Growth (2017-2022)
5 Americas
5.1 Americas Molecular Diagnostics in Point of Care Market Size by Country (2017-2022)
5.2 Americas Molecular Diagnostics in Point of Care Market Size by Type (2017-2022)
5.3 Americas Molecular Diagnostics in Point of Care Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Diagnostics in Point of Care Market Size by Region (2017-2022)
6.2 APAC Molecular Diagnostics in Point of Care Market Size by Type (2017-2022)
6.3 APAC Molecular Diagnostics in Point of Care Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Molecular Diagnostics in Point of Care by Country (2017-2022)
7.2 Europe Molecular Diagnostics in Point of Care Market Size by Type (2017-2022)
7.3 Europe Molecular Diagnostics in Point of Care Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Molecular Diagnostics in Point of Care by Region (2017-2022)
8.2 Middle East & Africa Molecular Diagnostics in Point of Care Market Size by Type (2017-2022)
8.3 Middle East & Africa Molecular Diagnostics in Point of Care Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Molecular Diagnostics in Point of Care Market Forecast
10.1 Global Molecular Diagnostics in Point of Care Forecast by Regions (2023-2028)
10.1.1 Global Molecular Diagnostics in Point of Care Forecast by Regions (2023-2028)
10.1.2 Americas Molecular Diagnostics in Point of Care Forecast
10.1.3 APAC Molecular Diagnostics in Point of Care Forecast
10.1.4 Europe Molecular Diagnostics in Point of Care Forecast
10.1.5 Middle East & Africa Molecular Diagnostics in Point of Care Forecast
10.2 Americas Molecular Diagnostics in Point of Care Forecast by Country (2023-2028)
10.2.1 United States Molecular Diagnostics in Point of Care Market Forecast
10.2.2 Canada Molecular Diagnostics in Point of Care Market Forecast
10.2.3 Mexico Molecular Diagnostics in Point of Care Market Forecast
10.2.4 Brazil Molecular Diagnostics in Point of Care Market Forecast
10.3 APAC Molecular Diagnostics in Point of Care Forecast by Region (2023-2028)
10.3.1 China Molecular Diagnostics in Point of Care Market Forecast
10.3.2 Japan Molecular Diagnostics in Point of Care Market Forecast
10.3.3 Korea Molecular Diagnostics in Point of Care Market Forecast
10.3.4 Southeast Asia Molecular Diagnostics in Point of Care Market Forecast
10.3.5 India Molecular Diagnostics in Point of Care Market Forecast
10.3.6 Australia Molecular Diagnostics in Point of Care Market Forecast
10.4 Europe Molecular Diagnostics in Point of Care Forecast by Country (2023-2028)
10.4.1 Germany Molecular Diagnostics in Point of Care Market Forecast
10.4.2 France Molecular Diagnostics in Point of Care Market Forecast
10.4.3 UK Molecular Diagnostics in Point of Care Market Forecast
10.4.4 Italy Molecular Diagnostics in Point of Care Market Forecast
10.4.5 Russia Molecular Diagnostics in Point of Care Market Forecast
10.5 Middle East & Africa Molecular Diagnostics in Point of Care Forecast by Region (2023-2028)
10.5.1 Egypt Molecular Diagnostics in Point of Care Market Forecast
10.5.2 South Africa Molecular Diagnostics in Point of Care Market Forecast
10.5.3 Israel Molecular Diagnostics in Point of Care Market Forecast
10.5.4 Turkey Molecular Diagnostics in Point of Care Market Forecast
10.5.5 GCC Countries Molecular Diagnostics in Point of Care Market Forecast
10.6 Global Molecular Diagnostics in Point of Care Forecast by Type (2023-2028)
10.7 Global Molecular Diagnostics in Point of Care Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Molecular Diagnostics in Point of Care Product Offered
11.1.3 Abbott Molecular Diagnostics in Point of Care Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Accelerate Diagnostics
11.2.1 Accelerate Diagnostics Company Information
11.2.2 Accelerate Diagnostics Molecular Diagnostics in Point of Care Product Offered
11.2.3 Accelerate Diagnostics Molecular Diagnostics in Point of Care Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Accelerate Diagnostics Main Business Overview
11.2.5 Accelerate Diagnostics Latest Developments
11.3 Ador Diagnostics
11.3.1 Ador Diagnostics Company Information
11.3.2 Ador Diagnostics Molecular Diagnostics in Point of Care Product Offered
11.3.3 Ador Diagnostics Molecular Diagnostics in Point of Care Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Ador Diagnostics Main Business Overview
11.3.5 Ador Diagnostics Latest Developments
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Information
11.4.2 Beckman Coulter Molecular Diagnostics in Point of Care Product Offered
11.4.3 Beckman Coulter Molecular Diagnostics in Point of Care Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Beckman Coulter Main Business Overview
11.4.5 Beckman Coulter Latest Developments
11.5 Becton, Dickinson and Company
11.5.1 Becton, Dickinson and Company Company Information
11.5.2 Becton, Dickinson and Company Molecular Diagnostics in Point of Care Product Offered
11.5.3 Becton, Dickinson and Company Molecular Diagnostics in Point of Care Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Becton, Dickinson and Company Main Business Overview
11.5.5 Becton, Dickinson and Company Latest Developments
11.6 Binx Health
11.6.1 Binx Health Company Information
11.6.2 Binx Health Molecular Diagnostics in Point of Care Product Offered
11.6.3 Binx Health Molecular Diagnostics in Point of Care Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Binx Health Main Business Overview
11.6.5 Binx Health Latest Developments
11.7 Biocartis
11.7.1 Biocartis Company Information
11.7.2 Biocartis Molecular Diagnostics in Point of Care Product Offered
11.7.3 Biocartis Molecular Diagnostics in Point of Care Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Biocartis Main Business Overview
11.7.5 Biocartis Latest Developments
11.8 bioM
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)